US Stock MarketDetailed Quotes

DRUG FREE SOLUTION INC (DSOL)

Watchlist
  • 0.0026
  • 0.00000.00%
15min DelayClose Apr 7 11:00 ET
736.85KMarket Cap-0.26P/E (TTM)

DRUG FREE SOLUTION INC (DSOL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Feb 28, 2014
(Q2)Nov 30, 2013
(Q1)Aug 31, 2013
(FY)May 31, 2013
(Q4)May 31, 2013
(Q3)Feb 28, 2013
(Q2)Nov 30, 2012
(Q1)Aug 31, 2012
(FY)May 31, 2012
(Q4)May 31, 2012
Total revenue
0
2.1K
0
0
0
0
0
0
0
-1.91K
Operating revenue
--0
--2.1K
--0
--0
--0
--0
--0
--0
--0
---1.91K
Cost of revenue
0
0
0
0
0
0
0
0
0
0
Gross profit
0
2.1K
0
0
0
0
0
0
0
-1.91K
Operating expense
4.88%120.35K
255.64%127.01K
-80.20%50.49K
37.82%755.87K
722.26%571.97K
-72.62%114.74K
118.86%35.71K
4,445.79%255.06K
548.44K
69.56K
Selling and administrative expenses
4.88%120.35K
177.21%99K
-80.20%50.49K
37.82%755.87K
722.26%571.97K
-72.62%114.74K
118.86%35.71K
4,445.79%255.06K
--548.44K
--69.56K
Research and development costs
--0
--28.01K
----
----
----
--0
--0
----
----
----
Operating profit
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-37.82%-755.87K
-700.24%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
-548.44K
-71.48K
Net non-operating interest income expense
Other net income (expense)
-77.15K
Special income (charges)
----
--0
--0
--0
----
----
--0
--0
---77.15K
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--77.15K
----
Income before tax
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-20.83%-755.87K
-284.84%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
-625.59K
-148.63K
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-20.83%-755.87K
-284.84%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
-625.59K
-148.63K
Net income continuous Operations
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-20.83%-755.87K
-284.84%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
---625.59K
---148.63K
Minority interest income
Net income attributable to the parent company
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-20.83%-755.87K
-284.84%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
-625.59K
-148.63K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.88%-120.35K
-249.76%-124.91K
80.20%-50.49K
-20.83%-755.87K
-284.84%-571.97K
72.60%-114.74K
-130.12%-35.71K
-4,445.79%-255.06K
-625.59K
-148.63K
Basic earnings per share
0
0
0
0.00%-0.01
-0.0067
0
0
-0.0033
-0.01
0
Diluted earnings per share
0
0
0
0.00%-0.01
-0.0067
0
0
-0.0033
-0.01
0
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Feb 28, 2014(Q2)Nov 30, 2013(Q1)Aug 31, 2013(FY)May 31, 2013(Q4)May 31, 2013(Q3)Feb 28, 2013(Q2)Nov 30, 2012(Q1)Aug 31, 2012(FY)May 31, 2012(Q4)May 31, 2012
Total revenue 02.1K0000000-1.91K
Operating revenue --0--2.1K--0--0--0--0--0--0--0---1.91K
Cost of revenue 0000000000
Gross profit 02.1K0000000-1.91K
Operating expense 4.88%120.35K255.64%127.01K-80.20%50.49K37.82%755.87K722.26%571.97K-72.62%114.74K118.86%35.71K4,445.79%255.06K548.44K69.56K
Selling and administrative expenses 4.88%120.35K177.21%99K-80.20%50.49K37.82%755.87K722.26%571.97K-72.62%114.74K118.86%35.71K4,445.79%255.06K--548.44K--69.56K
Research and development costs --0--28.01K--------------0--0------------
Operating profit -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-37.82%-755.87K-700.24%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K-548.44K-71.48K
Net non-operating interest income expense
Other net income (expense) -77.15K
Special income (charges) ------0--0--0----------0--0---77.15K----
-Less:Other special charges ----------------------------------77.15K----
Income before tax -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-20.83%-755.87K-284.84%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K-625.59K-148.63K
Income tax 0000000000
Net income -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-20.83%-755.87K-284.84%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K-625.59K-148.63K
Net income continuous Operations -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-20.83%-755.87K-284.84%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K---625.59K---148.63K
Minority interest income
Net income attributable to the parent company -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-20.83%-755.87K-284.84%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K-625.59K-148.63K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.88%-120.35K-249.76%-124.91K80.20%-50.49K-20.83%-755.87K-284.84%-571.97K72.60%-114.74K-130.12%-35.71K-4,445.79%-255.06K-625.59K-148.63K
Basic earnings per share 0000.00%-0.01-0.006700-0.0033-0.010
Diluted earnings per share 0000.00%-0.01-0.006700-0.0033-0.010
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
A major turning point has emerged in the US-Iran situation! Trump announced a two-week suspension of military action against Iran, and both Show More